| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $394.9M | +10.8% |
| R&D Expense | $46.7M | +10.1% |
| SG&A Expense | $78.6M | +7.3% |
| Operating Income | $72.4M | +26.2% |
| Pre-tax Income | $19.1M | +1015.5% |
| Income Tax | -$32.5M | -2632.0% |
| Net Income | $51.6M | — |
| EPS (Basic) | $1.20 | — |
| EPS (Diluted) | $1.20 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | -24.8% |
| Accounts Receivable | $86.0M | +25.5% |
| Inventory | $32.7M | -9.5% |
| Current Assets | $177.7M | +7.4% |
| Total Assets | $709.6M | +4.3% |
| Current Liabilities | $47.9M | +0.6% |
| Long-term Debt | $537.0M | -3.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $101.2M | +17.5% |
| Investing Cash Flow | -$71.7M | -21.9% |
| Financing Cash Flow | -$33.6M | -136.7% |
| Total Liabilities |
| $596.9M |
| -2.6% |
| Stockholders' Equity | $112.7M | +66.6% |